Anastrozole

CAS No.

120511-73-1

MDL No.

MFCD00866298

C₁₇H₁₉N₅

293.40

InChI Key

YBBLVLTVTVSKRW-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

On Request

Custom synthesis and bulk supply options are available upon request.

Product Information

Anastrozole is a 1,2,4-triazole compound with a 3,5-bis(2-cyano-2-propyl)benzyl group at the 1-position. It functions as an antineoplastic agent and an aromatase (EC 1.14.14.14) inhibitor. It is a triazole and a nitrile.

CAS No.	120511-73-1
Product Name	Anastrozole

Biological Targets

CYP19A1

Associated Conditions

triple-negative breast cancer·metabolic syndrome·Klinefelter's syndrome·breast disease·precocious puberty·

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Documentation

Anastrozole

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Related Articles

Update on endocrine aspects of breast cancer: report from the 23rd San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 6-9 December 2000.

Breast cancer chemoprevention: beyond tamoxifen.

The uterotrophic activity of nonylphenol in the rat is not mediated by aromatase enzyme induction.

Aromatase inhibitors in the treatment and prevention of breast cancer.

Documentation

Similar Products

Anastrozole 5-methyl analog